The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 evaluation of revumenib in patients with advanced colorectal cancer and other solid tumors.
 
Aparna Raj Parikh
Consulting or Advisory Role - Abbvie; Bayer; Biofidelity; Checkmate Pharmaceuticals; CVS; Delcath Systems; Foundation Medicine; Guardant Health; Illumina; Lilly; SAGA Diagnostics; Scarce; Seagen; Taiho Oncology; Takeda; UpToDate; Value Analytics Labs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Erasca, Inc; Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); PMV Pharma; PureTech (Inst)
Travel, Accommodations, Expenses - Karkinos Healthcare; Karkinos Healthcare
Other Relationship - C2i genomics; Parithera; Xact Robotics
 
Vedran Radojcic
Employment - Syndax
Stock and Other Ownership Interests - Syndax
Patents, Royalties, Other Intellectual Property - Syndax
 
Myles Clancy
Employment - Syndax
Stock and Other Ownership Interests - Black Diamond Therapeutics; Cullinan Oncology; Syndax
Patents, Royalties, Other Intellectual Property - Syndax
 
Susan Brouwer
Employment - Syndax
Stock and Other Ownership Interests - Syndax
 
Shaliny Kushwaha
Employment - Syndax
Stock and Other Ownership Interests - Syndax
 
Yifan Huang
Employment - Syndax
 
Nashat Gabrail
No Relationships to Disclose